| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 276.729 | 257.858 | 199.772 | 180.038 | 182.085 | 192.067 | 176.578 | 172.908 | 157.983 | 134.344 |
| Total Income - EUR | 276.729 | 258.014 | 199.772 | 180.941 | 182.085 | 192.067 | 176.578 | 172.918 | 157.983 | 134.344 |
| Total Expenses - EUR | 266.537 | 247.280 | 187.906 | 168.619 | 166.157 | 190.856 | 172.985 | 155.978 | 145.485 | 122.802 |
| Gross Profit/Loss - EUR | 10.193 | 10.734 | 11.866 | 12.322 | 15.929 | 1.210 | 3.594 | 16.940 | 12.498 | 11.542 |
| Net Profit/Loss - EUR | 8.419 | 8.965 | 8.431 | 10.522 | 14.108 | -560 | 1.828 | 15.211 | 10.918 | 10.198 |
| Employees | 0 | 0 | 4 | 4 | 4 | 3 | 0 | 3 | 3 | 2 |
Check the financial reports for the company - Viofarm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 15.321 | 10.063 | 5.168 | 2.494 | 2.189 | 1.998 | 1.807 | 1.665 | 1.540 | 1.532 |
| Current Assets | 189.201 | 167.857 | 187.981 | 185.624 | 185.339 | 173.008 | 164.437 | 181.362 | 183.321 | 195.726 |
| Inventories | 89.536 | 67.327 | 60.754 | 68.209 | 61.758 | 57.218 | 55.893 | 53.658 | 46.426 | 52.044 |
| Receivables | 57.173 | 52.467 | 82.795 | 82.496 | 74.981 | 59.618 | 56.227 | 64.981 | 62.612 | 68.438 |
| Cash | 42.492 | 48.064 | 44.431 | 34.919 | 48.601 | 56.172 | 52.317 | 62.722 | 74.283 | 75.244 |
| Shareholders Funds | 165.657 | 150.664 | 156.546 | 155.653 | 162.086 | 158.453 | 156.767 | 172.464 | 182.859 | 192.036 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 38.864 | 27.256 | 36.602 | 32.465 | 25.443 | 16.553 | 9.478 | 10.563 | 2.002 | 5.222 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Viofarm S.r.l.